SCHEMBL4926421

SCHEMBL4926421

Cc1ccnc(-c2c(Cl)nc3ncnn3c2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 1/20 0.41
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 5/20 0.40
TSHR P16473 3/20 0.40
HPGD P15428 2/20 0.40
PKM P14618 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
ENPP1 P22413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933864 0.80 NPSR1 (0.39) CCR1CCR5CCR8NPSR1HTT
SCHEMBL4933852 0.80 NPSR1 (0.39) CCR1CCR5CCR8NPSR1HTT
SCHEMBL8127031 0.78 ALDH1A1 (0.52) HTTKDM4EALDH1A1TSHRHPGD
SCHEMBL4929536 0.78 SMN1; SMN2 (0.33) KDM4EALDH1A1HPGDPKMNPC1
SCHEMBL4935032 0.78 KDM4E (0.41) CCR1CCR8HTTKDM4EALDH1A1
SCHEMBL5746844 0.77 ALDH1A1 (0.42) HTTKDM4EALDH1A1TSHRHPGD
SCHEMBL23944468 0.76 KDM4E (0.43) HTTKDM4EALDH1A1TSHRHPGD
SCHEMBL4930906 0.74 USP2 (0.40) KDM4EALDH1A1TSHRPKMKMT2A
SCHEMBL8487840 0.73 KDM4E (0.40) HTTKDM4EALDH1A1TSHRHPGD
SCHEMBL8686955 0.72 ALDH1A1 (0.47) NPSR1HTTKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227796-A1 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi BASF AKTIENGESELLSCHAFT (DE) 2008-09-18 US disclosed
EP-1828191-A2 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2007-09-05 EP disclosed
WO-2006066818-A2 7-AMINO-6-HETARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THE USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227796-A1 7-Amino-6-Hetaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and the Use Thereof for Controlling Pathogenic Fungi CYP8B1, CBR3, HDHD5 CCR1 337/4885CCR5 658/4885CCR8 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.